Compile Data Set for Download or QSAR
Report error Found 219 Enz. Inhib. hit(s) with Target = 'CX3C chemokine receptor 1'
TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CX3CR1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681308(US20240199558, Example 144 | N-(4-((R*)-2-(2,3-Dif...)
Affinity DataIC50: 13nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681300(US20240199558, Example 136 | N-(4-(2-(4-Amino-3-fl...)
Affinity DataIC50: 16nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681168(N-(4-((R*)-2-(3-Chloro-2-fluorophenyl)propyl)-6-((...)
Affinity DataIC50: 17nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681267(US20240199558, Example 103 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 17nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681249(US20240199558, Example 85 | N-(4-((R*)-2-(2-Fluoro...)
Affinity DataIC50: 18nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681285(US20240199558, Example 121 | N-(4-(2-(3-Aminopheny...)
Affinity DataIC50: 21nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681242(US20240199558, Example 78 | N-(4-((R*)-2-(2,6-Difl...)
Affinity DataIC50: 22nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681310(US20240199558, Example 146 | N-(4-((R*)-2-(2-Fluor...)
Affinity DataIC50: 23nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681270(US20240199558, Example 106 | N-(4-(2-(2,3-Dimethyl...)
Affinity DataIC50: 24nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681297(US20240199558, Example 133 | N-(4-(2-(3-Fluoro-4-(...)
Affinity DataIC50: 26nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681276(US20240199558, Example 112 | N-(4-(2-(4-Aminopheny...)
Affinity DataIC50: 29nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681206(N-(4-(((R)-1-Hydroxy-4-methylpentan-2-yl)amino)-6-...)
Affinity DataIC50: 30nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681215(N-(4-((R*)-2-(6-Aminopyridin-3-yl)propyl)-6-(((R)-...)
Affinity DataIC50: 30nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681252(US20240199558, Example 88 | N-(4-(((R)-1-Hydroxy-4...)
Affinity DataIC50: 32nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681183(N-(4-((R*)-2-(3-Fluoro-4-methoxyphenyl)propyl)-6-(...)
Affinity DataIC50: 33nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681255(US20240199558, Example 91 | N-(4-((R*)-2-(2-Fluoro...)
Affinity DataIC50: 34nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681274(US20240199558, Example 110 | N-(4-(2-(3,5-Difluoro...)
Affinity DataIC50: 34nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681311(US20240199558, Example 148 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 37nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681268(US20240199558, Example 104 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 38nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681190(N-(4-((R**)-2-(2-Chloropyridin-4-yl)propyl)-6-(((R...)
Affinity DataIC50: 44nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681278(US20240199558, Example 114 | N-(4-(2-(3-Amino-4-me...)
Affinity DataIC50: 45nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681240(US20240199558, Example 76 | N-(4-(((R)-1-Hydroxy-4...)
Affinity DataIC50: 48nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681245(US20240199558, Example 81 | N-(4-((R*)-2-(2-Fluoro...)
Affinity DataIC50: 49nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681198(N-(4-((R*)-2-(4-Chloro-2,3-difluorophenyl)propyl)-...)
Affinity DataIC50: 52nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681210(N-(4-((R*)-2-(4-Fluoro-6-methoxypyridin-3-yl)propy...)
Affinity DataIC50: 52nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681171(N-(4-((R*)-2-(5-Fluoro-6-methoxypyridin-3-yl)propy...)
Affinity DataIC50: 55nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681272(US20240199558, Example 108 | N-(4-(2-(Benzo[d][1,3...)
Affinity DataIC50: 58nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681211(N-(4-((R*)-2-(2,3-Difluorophenyl)butyl)-6-(((R)-1-...)
Affinity DataIC50: 63nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681204(N-(4-(((R)-1-Hydroxy-4-methylpentan-2-yl)amino)-6-...)
Affinity DataIC50: 65nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681250(US20240199558, Example 86 | N-(4-((S*)-2-(2-Fluoro...)
Affinity DataIC50: 73nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681225(N-(4-(2-(Benzo[d]oxazol-6-yl)propyl)-6-(((R)-1-hyd...)
Affinity DataIC50: 76nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681263(US20240199558, Example 99 | N-(4-(2-(2-Fluoro-3-me...)
Affinity DataIC50: 77nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681188(N-(4-((R*)-2-(2,5-Difluorophenyl)propyl)-6-(((R)-1...)
Affinity DataIC50: 78nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681281(US20240199558, Example 117 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 78nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681294(US20240199558, Example 130 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 79nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681273(US20240199558, Example 109 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 84nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681289(US20240199558, Example 125 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 85nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681266(US20240199558, Example 102 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 88nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681261(US20240199558, Example 97 | N-(4-(((R)-1-Hydroxy-4...)
Affinity DataIC50: 90nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681170(N-(4-((R*)-2-(2,4-Difluorophenyl)propyl)-6-(((R)-1...)
Affinity DataIC50: 96nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681224(N-(4-(2-(1H-Indol-5-yl)propyl)-6-(((R)-1-hydroxy-4...)
Affinity DataIC50: 102nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681258(US20240199558, Example 94 | N-(4-(((R)-1-Hydroxy-4...)
Affinity DataIC50: 102nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681299(US20240199558, Example 135 | N-(4-(2-(3-Fluoro-2-h...)
Affinity DataIC50: 104nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681222(N-(4-(2-(3-Fluorophenyl)propyl)-6-(((R)-1-hydroxy-...)
Affinity DataIC50: 105nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681306(US20240199558, Example 142 | N-(4-(2-(4-Fluoro-2-h...)
Affinity DataIC50: 110nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681221(N-(4-(((R)-1-Hydroxy-4-methylpentan-2-yl)amino)-6-...)
Affinity DataIC50: 111nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681256(US20240199558, Example 92 | N-(4-(((R)-1-Hydroxy-4...)
Affinity DataIC50: 112nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681271(US20240199558, Example 107 | N-(4-(2-(5-Chloro-2-h...)
Affinity DataIC50: 113nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM681227(N-(4-(2-(4-((Dimethyl(oxo)-λ6-sulfaneylidene)...)
Affinity DataIC50: 114nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 219 total ) | Next | Last >>
Jump to: